Atanas G. Atanasov
Atanas G. Atanasov
Leading Scientist. PI: #LBIDHPS. Editor-in-Chief: #CRBIOTECH. Executive Director: #INPST.
Verified email at univie.ac.at - Homepage
TitleCited byYear
Discovery and resupply of pharmacologically active plant-derived natural products: A review
AG Atanasov, B Waltenberger, EM Pferschy-Wenzig, T Linder, ...
Biotechnology advances 33 (8), 1582-1614, 2015
8772015
Natural product agonists of peroxisome proliferator-activated receptor gamma (PPARγ): a review
L Wang, B Waltenberger, EM Pferschy-Wenzig, M Blunder, X Liu, ...
Biochemical pharmacology 92 (1), 73-89, 2014
3792014
Hexose‐6‐phosphate dehydrogenase determines the reaction direction of 11β‐hydroxysteroid dehydrogenase type 1 as an oxoreductase
AG Atanasov, LG Nashev, RAS Schweizer, C Frick, A Odermatt
FEBS letters 571 (1-3), 129-133, 2004
2292004
Ethnopharmacological in vitro studies on Austria's folk medicine—An unexplored lore in vitro anti-inflammatory activities of 71 Austrian traditional herbal drugs
S Vogl, P Picker, J Mihaly-Bison, N Fakhrudin, AG Atanasov, EH Heiss, ...
Journal of ethnopharmacology 149 (3), 750-771, 2013
1912013
A rapid screening assay for inhibitors of 11β-hydroxysteroid dehydrogenases (11β-HSD): flavanone selectively inhibits 11β-HSD1 reductase activity
RAS Schweizer, AG Atanasov, BM Frey, A Odermatt
Molecular and cellular endocrinology 212 (1-2), 41-49, 2003
1292003
Activated AMPK boosts the Nrf2/HO-1 signaling axis—a role for the unfolded protein response
K Zimmermann, J Baldinger, B Mayerhofer, AG Atanasov, VM Dirsch, ...
Free Radical Biology and Medicine 88, 417-426, 2015
1132015
Honokiol: a non-adipogenic PPARγ agonist from nature
AG Atanasov, JN Wang, SP Gu, J Bu, MP Kramer, L Baumgartner, ...
Biochimica et Biophysica Acta (BBA)-General Subjects 1830 (10), 4813-4819, 2013
1102013
Inflammatory markers for arterial stiffness in cardiovascular diseases
I Mozos, C Malainer, J Horbańczuk, C Gug, D Stoian, CT Luca, ...
Frontiers in immunology 8, 1058, 2017
912017
Why is 11β-hydroxysteroid dehydrogenase type 1 facing the endoplasmic reticulum lumen?: Physiological relevance of the membrane topology of 11β-HSD1
A Odermatt, AG Atanasov, Z Balazs, RAS Schweizer, LG Nashev, ...
Molecular and cellular endocrinology 248 (1-2), 15-23, 2006
872006
Inhibition of 11β-hydroxysteroid dehydrogenase type 2 by dithiocarbamates
AG Atanasov, S Tam, JM Röcken, ME Baker, A Odermatt
Biochemical and biophysical research communications 308 (2), 257-262, 2003
822003
Organotins disrupt the 11β-Hydroxysteroid Dehydrogenase Type 2–dependent local inactivation of glucocorticoids
AG Atanasov, LG Nashev, S Tam, ME Baker, A Odermatt
Environmental health perspectives 113 (11), 1600-1606, 2005
782005
Autophagy and Alzheimer’s disease: from molecular mechanisms to therapeutic implications
M Uddin, A Stachowiak, AA Mamun, NT Tzvetkov, S Takeda, AG Atanasov, ...
Frontiers in aging neuroscience 10, 4, 2018
752018
Disruption of glucocorticoid action by environmental chemicals: potential mechanisms and relevance
A Odermatt, C Gumy, AG Atanasov, AA Dzyakanchuk
The Journal of steroid biochemistry and molecular biology 102 (1-5), 222-231, 2006
752006
A critical analysis of extraction techniques used for botanicals: Trends, priorities, industrial uses and optimization strategies
T Belwal, SM Ezzat, L Rastrelli, ID Bhatt, M Daglia, A Baldi, HP Devkota, ...
TrAC Trends in Analytical Chemistry 100, 82-102, 2018
742018
Natural products to counteract the epidemic of cardiovascular and metabolic disorders
B Waltenberger, A Mocan, K Šmejkal, EH Heiss, AG Atanasov
Molecules 21 (6), 807, 2016
712016
Direct protein–protein interaction of 11β-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase in the endoplasmic reticulum lumen
AG Atanasov, LG Nashev, L Gelman, B Legeza, R Sack, R Portmann, ...
Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1783 (8), 1536-1543, 2008
702008
The role of nutraceuticals in statin intolerant patients
M Banach, AM Patti, RV Giglio, AFG Cicero, AG Atanasov, G Bajraktari, ...
Journal of the American College of Cardiology 72 (1), 96-118, 2018
662018
Computer-aided discovery, validation, and mechanistic characterization of novel neolignan activators of peroxisome proliferator-activated receptor γ
N Fakhrudin, A Ladurner, AG Atanasov, EH Heiss, L Baumgartner, ...
Molecular pharmacology 77 (4), 559-566, 2010
642010
Readjusting the glucocorticoid balance: an opportunity for modulators of 11β-hydroxysteroid dehydrogenase type 1 activity?
AG Atanasov, A Odermatt
Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug …, 2007
612007
Bioactivity-Guided Isolation of 1,2,3,4,6-Penta-O-galloyl-d-glucopyranose from Paeonia lactiflora Roots As a PTP1B Inhibitor
RR Baumgartner, D Steinmann, EH Heiss, AG Atanasov, M Ganzera, ...
Journal of natural products 73 (9), 1578-1581, 2010
592010
The system can't perform the operation now. Try again later.
Articles 1–20